Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 2366-2371, May 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uno, K.
Right arrow Articles by Muramatsu, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uno, K.
Right arrow Articles by Muramatsu, S.

Effect of Recombinant Human Interferon-{alpha}A/D on in Vivo Murine Tumor Cell Growth1

Kazuko Uno, Satoshi Shimizu, Kayo Inaba, Makoto Kitaura, Kensuke Nakahira, Takuma Kato, Yasunori Yamaguchi and Shigeru Muramatsu2

Department of Zoology, Faculty of Science, Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-ku, Kyoto 606 [K. U., S. S., K. I., M. K., K. N., T. K., Y. Y., S. M.] and Kyoto Pasteur Institute 425, Yamamoto-cho, Gokomachi-dori, Oshikojiagaru, Nakagyo-ku, Kyoto 604 [K. U.], Japan

We investigated the effect of human recombinant interferon-{alpha}A/D (A/D-IFN), which is known to delay the growth of murine tumor cells, on the growth of S1 and R1 subline cells of murine Meth A fibrosarcoma in the peritoneal cavity of mice. In vitro growth of S1 cells was sensitive to, and that of R1 cells was resistant to, the direct effect of A/D-IFN, as with murine natural IFN-{alpha}/ß, which was used originally to isolate these sublines. In vivo, however, the growth of not only S1 cells but also R1 cells was suppressed by the administration of A/D-IFN, and the survival time of tumor-bearing mice was prolonged. Although A/D-IFN had a direct effect on S1 cells in vivo, R1 cells were susceptible only to the indirect effect via the host cells. Macrophages (Mø) harvested from the peritoneal cavity of A/D-IFN-treated mice bearing ascitic R1 cells were very effective in suppressing the in vitro growth of R1 cells; those from non-R1-bearing A/D-IFN-treated mice were less effective. The results of in vitro experiments indicate that Mø are very probably activated by the synergism of A/D-IFN and Mø-activating factor(s) produced by lymphoid cells in tumor-bearing mice.

1 This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture of Japan, and a Shimizu Foundation Research Grant.

2 To whom requests for reprints should be addressed, at Department of Zoology, Faculty of Science, Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-Ku, Kyoto, 606 Japan.

Received 2/16/87. Revised 8/10/87. Revised 1/11/88. Accepted 1/22/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.